Skip to main content
DAEWOONG CO.,LTD logo

DAEWOONG CO.,LTD — Investor Relations & Filings

Ticker · 003090 ISIN · KR7003090008 KO Manufacturing
Open in API
Filings indexed 311 across all filing types
Latest filing 2020-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 003090

About DAEWOONG CO.,LTD

https://www.daewoong.co.kr

Daewoong Co., Ltd. is a holding company operating primarily in the biotechnology and healthcare sectors. Its core business, conducted through subsidiaries like Daewoong Pharmaceutical, involves the research, development, manufacturing, and commercialization of a broad range of pharmaceutical products. The company's portfolio includes prescription drugs, over-the-counter (OTC) medications, quasi-drugs, and active pharmaceutical ingredients (APIs). Daewoong focuses on developing innovative drugs, with established expertise in gastrointestinal and endocrine therapeutic areas. A key product in its global portfolio is Nabota, an FDA-approved botulinum toxin. The company emphasizes continuous R&D and engages in open collaboration to develop new healthcare solutions.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Daewoong Co., Ltd. for the first quarter of 2020 (January 1, 2020, to March 31, 2020). It contains detailed corporate information, business descriptions, capital structure, and financial data, which is characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. Q1 2020
2020-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. It details the sale of shares by an executive (Lee Geon-haeng) of Daewoong Co., Ltd. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) in the provided schema, as it reports personal share transactions by company directors and executives.
2020-04-28 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Daewoong Co., Ltd. for the fiscal year ending December 31, 2019. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a formal financial audit document, not an announcement or a summary, and fits the definition of an Audit Report (AR). FY 2019
2020-03-30 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) from Daewoong Co., Ltd. It details specific changes in share ownership by company executives and major shareholders, including names, dates of change, and the number of shares held. This type of filing is a standard regulatory disclosure for insider/major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category as it reports personal share transactions by company directors and executives.
2020-03-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used by executives to report changes in their personal shareholdings in the company. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2020-03-25 Korean
현금ㆍ현물배당결정(자회사의 주요경영사항)
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding a decision to pay dividends (현금ㆍ현물 배당 결정). It specifies the dividend amount per share, the total dividend amount, the record date, and the payment date. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2020-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.